Issues of Medical Intractability for Surgical Candidacy

Oct 17, 2016 by in NEUROLOGY Comments Off on Issues of Medical Intractability for Surgical Candidacy

Issues of Medical Intractability for Surgical Candidacy Patrick Kwan Martin J. Brodie INTRODUCTION Although the effectiveness of epilepsy surgery for patients with surgically remediable syndromes refractory to antiepileptic drug (AED)…

read more

Vagus Nerve Stimulation Therapy

Oct 17, 2016 by in NEUROLOGY Comments Off on Vagus Nerve Stimulation Therapy

Vagus Nerve Stimulation Therapy James W. Wheless Epilepsy and seizures affect at least 2.3 million individuals in the United States (1). Although antiepileptic drugs (AEDs) are the primary form of…

read more

The Ketogenic Diet

Oct 17, 2016 by in NEUROLOGY Comments Off on The Ketogenic Diet

The Ketogenic Diet Douglas R. Nordli Jr. Darryl C. De Vivo INTRODUCTION The ketogenic diet is a high-fat, low-carbohydrate, low-protein regimen that has been used for more than 70 years…

read more

Less Commonly Used Antiepileptic Drugs

Oct 17, 2016 by in NEUROLOGY Comments Off on Less Commonly Used Antiepileptic Drugs

Less Commonly Used Antiepileptic Drugs Basim M. Uthman Ahmad Beydoun INTRODUCTION Despite the availability of a large number of marketed antiepileptic drugs (AEDs), physicians use only a few to treat…

read more

Newer Antiepileptic Drugs

Oct 17, 2016 by in NEUROLOGY Comments Off on Newer Antiepileptic Drugs

Newer Antiepileptic Drugs Norman Delanty Jacqueline A. French Despite advances and optimal current therapy, there remains a continuing need for the development of new agents for patients with epilepsy (1,…

read more

Adrenocorticotropin and Steroids

Oct 17, 2016 by in NEUROLOGY Comments Off on Adrenocorticotropin and Steroids

Adrenocorticotropin and Steroids Melinda A. Nolan O. Carter Snead III HISTORICAL BACKGROUND The first report of the efficacy of adrenocorticotropin (ACTH) therapy for childhood seizures appeared in 1950, when Klein…

read more

Vigabatrin

Oct 17, 2016 by in NEUROLOGY Comments Off on Vigabatrin

Vigabatrin Elinor Ben-Menachem HISTORICAL BACKGROUND Although it was known that decreases in brain gamma-aminobutyric acid (GABA) caused convulsions in animals and agents that enhanced GABA-mediated functions could have an anticonvulsant…

read more

Felbamate

Oct 17, 2016 by in NEUROLOGY Comments Off on Felbamate

Felbamate Edward Faught HISTORICAL BACKGROUND When felbamate (FBM) was introduced to clinical practice in the United States in July 1993, there had been no major new antiepileptic drugs (AEDs) for…

read more

Tiagabine

Oct 17, 2016 by in NEUROLOGY Comments Off on Tiagabine

Tiagabine Steven C. Schachter HISTORICAL BACKGROUND AND CHEMISTRY Tiagabine (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl] nipecotic acid hydrochloride (TGB; Gabitril, Abbot Laboratories, Cephalon, Inc. West Chester, Pennsylvania) received regulatory clearance from the US Food and…

read more

Levetiracetam

Oct 17, 2016 by in NEUROLOGY Comments Off on Levetiracetam

Levetiracetam Joseph I. Sirven Joseph F. Drazkowski Levetiracetam (LEV) is a novel antiepileptic drug (AED) approved in 2000 by the US Food and Drug Administration as adjunctive therapy for patients…

read more
Get Clinical Tree app for offline access